Home / Resources / The Annual Clinical Trials Roundup 2024 Edition: Promising Road to Recovery

The Annual Clinical Trials Roundup 2024 Edition: Promising Road to Recovery

Infographic
Clinical
Citeline Clinical Infographic: A Promising Rebound Selected Insights from the Annual Clinical Trials Roundup: 2024 Edition

Trialtrove captured 9,959 Phase I–III clinical trials with a 2024 start date investigating at least one drug, an 9.4% increase from the previous year and a recovery from 2022’s 12.5% decline in trial starts.

Related products
Professional using a laptop device to access Trialtrove for trial insights and strategy.
Trialtrove
The go-to resource for informing clinical trial strategy, design and execution
Digital map showcasing the reach of Sitetrove, providing data from trial sites across the globe.
Sitetrove
The industry-leading suite of global clinical trial investigator and site intelligence
Citeline subscriber exploring the diversity feasibility using Global Patient Insights.
Global Patient Insights
Enabling sponsors to optimize investigator selection and hit diversity goals faster

Related resources

The Annual Clinical Trials Roundup 2024 Edition: Promising Road to Recovery
OCT 02, 2024
White paper
Clinical

The Annual Clinical Trials Roundup 2024 Edition: Promising Road to Recovery

The 2024 Clinical Trials Round focuses on Phase I–III clinical trials that initiated in 2023 across all therapeutic areas covered by Citeline’s Trialtrove.

Exploring Clinical Trial Delays_resource-card-thumbnail
NOV 28, 2023
Article
Clinical

Exploring Clinical Trial Delays

We analyzed data from trials completed during the pandemic to identify trials whose primary completion dates were pushed back by more than six months.

3D model of a RNA strand.
JUL 30, 2024
Report
Commercial

Q2 2024 Gene, Cell, + RNA Therapy Landscape Report

In this report, by Citeline and the American Society of Gene & Cell Therapy (ASGCT), new approvals in Q2 2024 were focused on the RNA landscape.

View all